ATE400584T1 - Neuer ligand und dna davon - Google Patents

Neuer ligand und dna davon

Info

Publication number
ATE400584T1
ATE400584T1 AT02736088T AT02736088T ATE400584T1 AT E400584 T1 ATE400584 T1 AT E400584T1 AT 02736088 T AT02736088 T AT 02736088T AT 02736088 T AT02736088 T AT 02736088T AT E400584 T1 ATE400584 T1 AT E400584T1
Authority
AT
Austria
Prior art keywords
bovine
gpr7
gpr8
peptides
polynucleotides encoding
Prior art date
Application number
AT02736088T
Other languages
English (en)
Inventor
Shuji Hinuma
Ryo Fujii
Shoji Fukusumi
Masaaki Mori
Hiromi Yoshida
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE400584T1 publication Critical patent/ATE400584T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
AT02736088T 2001-06-14 2002-06-13 Neuer ligand und dna davon ATE400584T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001180562 2001-06-14
JP2001216773 2001-07-17
JP2001359826 2001-11-26
JP2001401019 2001-12-28
JP2002154533 2002-05-28

Publications (1)

Publication Number Publication Date
ATE400584T1 true ATE400584T1 (de) 2008-07-15

Family

ID=27531924

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02736088T ATE400584T1 (de) 2001-06-14 2002-06-13 Neuer ligand und dna davon

Country Status (6)

Country Link
US (1) US7268212B2 (de)
EP (1) EP1403281B1 (de)
AT (1) ATE400584T1 (de)
CA (1) CA2450442A1 (de)
DE (1) DE60227519D1 (de)
WO (1) WO2002102847A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057236A1 (fr) * 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Inhibiteur de prise de poids corporel
AU2003221533A1 (en) * 2002-03-29 2003-10-13 Euroscreen Sa Ligands for g protein coupled receptor gpr7 and uses thereof
WO2004080485A1 (ja) * 2003-03-13 2004-09-23 Takeda Pharmaceutical Company 上部消化管疾患の予防・治療剤
JP4504098B2 (ja) * 2003-05-28 2010-07-14 武田薬品工業株式会社 抗体およびその用途
WO2004106382A1 (ja) * 2003-05-28 2004-12-09 Takeda Pharmaceutical Company Limited 抗体およびその用途
ITMI20041569A1 (it) * 2004-07-30 2004-10-30 Tecnogen Scpa "ligandi peptidici specifici per le immunoglobuline"
EP2162534B1 (de) * 2007-05-24 2014-07-23 Apceth GmbH & Co. KG Genetisch veränderte CD34 negative mesenchymale Stammzellen für die Tumorbehandlung
JP5378469B2 (ja) 2011-08-11 2013-12-25 学校法人 日本歯科大学 医療用薬剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591602A (en) * 1993-11-05 1997-01-07 O'dowd; Brian F. Nucleic acid encoding opioid receptor
CA2413195C (en) * 2000-06-21 2012-01-17 Takeda Chemical Industries, Ltd. Ligand to gpr8 and dna thereof
EP1344823A4 (de) * 2000-11-30 2005-03-16 Takeda Chemical Industries Ltd Neue g-protein-gekoppelte rezeptorproteine und deren dnas
EP1378749A4 (de) 2001-04-12 2005-05-11 Takeda Pharmaceutical Screening-verfahren
WO2002093161A1 (fr) 2001-05-15 2002-11-21 Takeda Chemical Industries, Ltd. Methode de balayage
WO2003057236A1 (fr) 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Inhibiteur de prise de poids corporel

Also Published As

Publication number Publication date
CA2450442A1 (en) 2002-12-27
WO2002102847A1 (fr) 2002-12-27
EP1403281B1 (de) 2008-07-09
EP1403281A1 (de) 2004-03-31
US20040220384A1 (en) 2004-11-04
US7268212B2 (en) 2007-09-11
DE60227519D1 (de) 2008-08-21
EP1403281A4 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
Zougman et al. Integrated analysis of the cerebrospinal fluid peptidome and proteome
Sun et al. Mosaic mutant analysis identifies PDGFRα/PDGFRβ as negative regulators of adipogenesis
US6987172B2 (en) Multifunctional single chain glycoprotein hormones comprising three or more β subunits
CN1058782A (zh) 上皮蛋白(Epithclins)：新的富含半胱氨酸的生长调节蛋白质
RU2008102731A (ru) Новое биологическое вещество несфатин, родственные ему вещества и их применение
CA2309903A1 (en) Nucleic acid sequences encoding capsaicin receptor
JP2004536585A5 (de)
JP2005520834A (ja) 小細胞肺癌の同定、診断、および治療のための方法および組成物
DE60227519D1 (de) Neuer ligand und dna davon
JP2000516456A (ja) 視床下部特異的ポリペプチド
ATE319092T1 (de) Screeningverfahren
WO2007004692A1 (ja) 非小細胞肺がんの予防・治療剤および診断薬
Vercauteren et al. An organelle proteomic method to study neurotransmission‐related proteins, applied to a neurodevelopmental model of schizophrenia
Boja et al. Structural conservation of mouse and rat zona pellucida glycoproteins. Probing the native rat zona pellucida proteome by mass spectrometry
JP4654029B2 (ja) 単一ドメインｔｄｆ関連化合物およびその類似体
JP2008509659A5 (de)
WO2001081562A1 (fr) Nouveaux polypeptides appartenant a la famille insuline/igf/relaxine et adn correspondants
US20060292639A1 (en) Splice variant of the vanilloid receptor VR1A
JP2003529371A (ja) ヒトセリンラセマーゼ
JP3349514B2 (ja) Ｉｃａｍ−４物質及び方法
WO2003020913A3 (en) Anopheles gambiae odorant receptors and genes
WO2000071581A1 (fr) Nouveau polypeptide
JP2005528886A5 (de)
JPH044873A (ja) ペプチドｃ末端アミド化酵素の製造方法
CA2437866A1 (en) Novel clock gene bmal2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties